Treatment Dynamics And Disease Burden Among Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Currently Treated With Disease Modifying Treatments (Dmts) In The United States

Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking Injectable and Oral Disease Modifying Treatments in the United States

Value in Health ◽

10.1016/j.jval.2014.08.933 ◽

2014 ◽

Vol 17 (7) ◽

pp. A404-A405

Author(s):

S. Narayanan ◽

P. O'Meara ◽

J. White ◽

J. Chan ◽

S. Gabriele

Keyword(s):

United States ◽

Multiple Sclerosis ◽

The United States ◽

Oral Disease ◽

Relapsing Remitting ◽

Disease Modifying ◽

Comparison of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Treated With Disease Modifying Treatments (Dmt) In Europe (Eu) And The United States (Us)

Value in Health ◽

10.1016/j.jval.2015.09.2513 ◽

2015 ◽

Vol 18 (7) ◽

pp. A766

Author(s):

S Narayanan ◽

P O’Meara ◽

J White ◽

J Chan ◽

R Hooper ◽

...

Keyword(s):

United States ◽

Multiple Sclerosis ◽

The United States ◽

Relapsing Remitting ◽

Disease Modifying ◽

Adoption of Oral Disease Modifying Treatments to Manage Patients with Relapsing Remitting Multiple Sclerosis from 2011-2013 in the United States

Value in Health ◽

10.1016/j.jval.2014.08.934 ◽

2014 ◽

Vol 17 (7) ◽

pp. A405

Author(s):

S. Narayanan ◽

P. O'Meara ◽

J. White ◽

J. Chan ◽

S. Gabriele ◽

...

Keyword(s):

United States ◽

Multiple Sclerosis ◽

The United States ◽

Oral Disease ◽

Relapsing Remitting ◽

Disease Modifying ◽

Treatment patterns of relapsing remitting multiple sclerosis (RRMS) in Europe and the United States

10.26226/morressier.59a3edacd462b8028d8958b7 ◽

2017 ◽

Author(s):

Joanna White

Keyword(s):

United States ◽

Multiple Sclerosis ◽

The United States ◽

Treatment Patterns ◽

Relapsing Remitting ◽

PND44 Assessing Variations in Transitions in Employment in Relapsing-Remitting Multiple Sclerosis Patients Treated With Either Laquinimod, Interferon Beta 1-a or Placebo: Expoloratory Evidence From the United States Substudy of Bravo

Value in Health ◽

10.1016/j.jval.2012.03.803 ◽

2012 ◽

Vol 15 (4) ◽

pp. A149

Author(s):

C.A. Carroll ◽

M.A. Oleen-Burkey

Keyword(s):

United States ◽

Multiple Sclerosis ◽

Interferon Beta ◽

The United States ◽

Relapsing Remitting ◽

Multiple Sclerosis Patients ◽

Cost-Effectiveness of Daclizumab Versus Interferon Beta-1A in the Treatment of Patients with Relapsing-Remitting Multiple Sclerosis in the United States

Value in Health ◽

10.1016/j.jval.2018.04.1400 ◽

2018 ◽

Vol 21 ◽

pp. S206

Author(s):

D Rao ◽

E Heidari ◽

KM Kamal ◽

AA Dashputre

Keyword(s):

United States ◽

Multiple Sclerosis ◽

Cost Effectiveness ◽

Interferon Beta ◽

The United States ◽

Relapsing Remitting ◽

Heatlh Care Costs Associated with Patients Diagnosed with Relapsing Remitting Multiple Sclerosis Taking Once Daily Teriflunomide Tablets in the United States

Value in Health ◽

10.1016/j.jval.2015.09.054 ◽

2015 ◽

Vol 18 (7) ◽

pp. A878

Author(s):

N Greene ◽

M Greene

Keyword(s):

United States ◽

Multiple Sclerosis ◽

The United States ◽

Once Daily ◽

Relapsing Remitting ◽

Relapsing Remitting Multiple Sclerosis ◽

Care Costs

Patterns of Use of Tests to Monitor Disease Activity Among Patients With Relapsing Remitting Multiple Sclerosis in the United States and Europe

Value in Health ◽

10.1016/j.jval.2014.08.929 ◽

2014 ◽

Vol 17 (7) ◽

pp. A404

Author(s):

S. Narayanan ◽

P. O'Meara ◽

J. White ◽

J. Chan ◽

S. Gabriele

Keyword(s):

United States ◽

Multiple Sclerosis ◽

Disease Activity ◽

The United States ◽

Patterns Of Use ◽

Relapsing Remitting ◽

Fingolimod Versus Teiflunomide: Health Care Costs Associated With Patients Diagnosed With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Therapies In The United States

Value in Health ◽

10.1016/j.jval.2016.03.221 ◽

2016 ◽

Vol 19 (3) ◽

pp. A69

Author(s):

M Greene ◽

N Greene

Keyword(s):

United States ◽

Multiple Sclerosis ◽

Health Care ◽

Health Care Costs ◽

The United States ◽

Disease Modifying Therapies ◽

Relapsing Remitting ◽

Disease Modifying ◽

Relapsing Remitting Multiple Sclerosis ◽

Care Costs

Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice Experiment

Patient Preference and Adherence ◽

10.2147/ppa.s306498 ◽

2021 ◽

Vol Volume 15 ◽

pp. 1515-1527

Author(s):

Jinender Kumar ◽

M Janelle Cambron-Mellott ◽

Tom Tencer ◽

Oliver Will ◽

deMauri S Mackie ◽

...

Keyword(s):

United States ◽

Multiple Sclerosis ◽

Discrete Choice Experiment ◽

Discrete Choice ◽

Choice Experiment ◽

The United States ◽

Relapsing Remitting ◽